This content is for AHPRA registered professionals only. Login Join Now
TGA greenlights second daily GLP-1 pill
Orforglipron is the first small-molecule, non-peptide GLP-1 receptor agonist of its kind and is expected to be available to patients within days. See how much it is expected to cost.



